Published October, 2013
By Bruno Horisberger and Wilhelm Van Eimeren
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Health Systems Research
Rating:
Availability: Available

These questions, and those related to the intriguing search for better quality of life, are addressed in this book by experts from the fields of medicine, epidemiology, economics, sociology and the pharmaceutical industry.

---

Published December, 2011
By Bruno Horisberger and Rolf Dinkel
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Health Systems Research
Rating:
Availability: Available

In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Drug risk and drug safety have become an important political issue. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened.

---

Published December, 2011
By A.J. Culyer, Bruno Horisberger, Bryan R. Luce and Anne Elixhauser
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Health Systems Research
Rating:
Availability: Available

Over the past decades, health care delivery - once characterized by clearly defined relationships between medical professionals, regulators, and industr- has become much more complex. They bring into the discussion the need for cost containment and the changing perceptions of the public with regard to the risks and benefits of health care outcomes.

---

Published September, 2011
By Bruno Horisberger, Rolf Dinkel and Kenneth W. Tolo
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Health Systems Research
Rating:
Availability: Available

As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety?

---